GGrantIndex
← Leaderboards

Denise A. Galloway

Fred Hutchinson Cancer Center

Google Scholar ↗PubMed ↗ORCID ↗
$30,691,532
Attributed
$32,652,836
Total exposure
14
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.3M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$49,564,561 · 15

By mechanism

P01$21,623,901 · 5
R01$17,674,853 · 5
R35$6,514,016 · 1
R37$3,042,394 · 1
P30$504,988 · 2
U54$204,409 · 1

Top collaborators

Most similar at Fred Hutchinson Cancer Center

Same institution · by research overlap

Others in their field

Top investigators on “Human Papillomavirus”

Research focus

Human PapillomavirusProteinsMalignant NeoplasmsMutationVirusInfectionResponsePreventPlayBasePolyomavirusGenesVaccinesTelomerasePathway InteractionsBinding (Molecular Function)Human Papilloma Virus InfectionViralMerkel CellsAnogenital CancerNatural HistoryInsightCapsidCells

Grant awards (86)

Pathogen Associated Malignancies$104,511
P30 · FY2025 · CA · contact PI
Research Program: Pathogen Associated Malignancies$80,939
P30 · FY2024 · CA · contact PI
Human Papillomavirus and Polyomavirus Associated Malignancies.$1,010,057
R35 · FY2023 · CA · contact PI
Research Program: Pathogen Associated Malignancies$80,941
P30 · FY2023 · CA · contact PI
Human Papillomavirus and Polyomavirus Associated Malignancies.$1,018,780
R35 · FY2022 · CA · contact PI
Research Program: Pathogen Associated Malignancies$80,941
P30 · FY2022 · CA · contact PI
Human Papillomavirus and Polyomavirus Associated Malignancies.$521,176
R35 · FY2021 · CA · contact PI
Human Papillomavirus and Polyomavirus Associated Malignancies.$487,115
R35 · FY2021 · CA · contact PI
Research Program: Pathogen Associated Malignancies$75,881
P30 · FY2021 · CA · contact PI
Human Papillomavirus and Polyomavirus Associated Malignancies.$1,040,514
R35 · FY2020 · CA · contact PI
HPV Capsid Antibodies$480,737
R01 · FY2020 · AI · contact PI
Research Program: Pathogen Associated Malignancies$81,775
P30 · FY2020 · CA · contact PI
Human Papillomavirus and Polyomavirus Associated Malignancies.$897,756
R35 · FY2019 · CA · contact PI
HPV Capsid Antibodies$480,737
R01 · FY2019 · AI · contact PI
Human Papillomavirus and Polyomavirus Associated Malignancies.$1,041,403
R35 · FY2018 · CA · contact PI
HPV Capsid Antibodies$480,737
R01 · FY2018 · AI · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$523,373
R01 · FY2017 · CA · contact PI
Human Papillomavirus and Polyomavirus Associated Malignancies.$497,215
R35 · FY2017 · CA · contact PI
HPV Capsid Antibodies$480,737
R01 · FY2017 · AI · contact PI
The Role of ALTO in the MCPyV Lifecycle and Tumorigenicity$365,200
R01 · FY2017 · CA · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$523,373
R01 · FY2016 · CA · contact PI
HPV Capsid Antibodies$480,737
R01 · FY2016 · AI · contact PI
The Role of ALTO in the MCPyV Lifecycle and Tumorigenicity$365,200
R01 · FY2016 · CA · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$529,838
R01 · FY2015 · CA · contact PI
Novel Pathogen Associated Cancers (PQ12)$371,081
R01 · FY2015 · CA · contact PI
The Role of ALTO in the MCPyV Lifecycle and Tumorigenicity$365,200
R01 · FY2015 · CA · contact PI
Novel Pathogen Associated Cancers (PQ12)$722,856
R01 · FY2014 · CA · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$515,950
R01 · FY2014 · CA · contact PI
HPV Capsid Antibodies$395,851
R01 · FY2014 · AI · contact PI
The Role of ALTO in the MCPyV Lifecycle and Tumorigenicity$365,200
R01 · FY2014 · CA · contact PI
Novel Pathogen Associated Cancers (PQ12)$736,412
R01 · FY2013 · CA · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$501,980
R01 · FY2013 · CA · contact PI
HPV Capsid Antibodies$370,608
R01 · FY2013 · AI · contact PI
Strategies to Prevent and Treat EV71 Infection$204,409
U54 · FY2013 · AI · contact PI
Novel Pathogen Associated Cancers (PQ12)$784,723
R01 · FY2012 · CA · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$536,175
R01 · FY2012 · CA · contact PI
HPV Capsid Antibodies$403,429
R01 · FY2012 · AI · contact PI
HPV: Biology, Clinical Significance and Epidemiology$1,952,686
P01 · FY2011 · CA · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$538,372
R01 · FY2011 · CA · contact PI
HPV Capsid Antibodies$380,590
R01 · FY2011 · AI · contact PI
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS$378,176
P01 · FY2011 · CA · contact PI
MOLECULAR BIOLOGY$312,187
P01 · FY2011 · CA · contact PI
HPV: Biology, Clinical Significance and Epidemiology$2,278,913
P01 · FY2010 · CA · contact PI
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS$430,239
P01 · FY2010 · CA · contact PI
HPV Capsid Antibodies$405,044
R01 · FY2010 · AI · contact PI
MOLECULAR BIOLOGY$367,073
P01 · FY2010 · CA · contact PI
HPV: Biology, Clinical Significance and Epidemiology$2,414,027
P01 · FY2009 · CA · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$565,396
R01 · FY2009 · CA · contact PI
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS$423,614
P01 · FY2009 · CA · contact PI
MOLECULAR BIOLOGY$387,303
P01 · FY2009 · CA · contact PI
HPV CAPSID ANTIBODIES$316,089
R37 · FY2009 · AI · contact PI
HPV: Biology, Clinical Significance and Epidemiology$215,373
P01 · FY2009 · CA · contact PI
HPV: Biology, Clinical Significance and Epidemiology$2,263,372
P01 · FY2008 · CA · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$548,928
R01 · FY2008 · CA · contact PI
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS$415,175
P01 · FY2008 · CA · contact PI
MOLECULAR BIOLOGY$341,245
P01 · FY2008 · CA · contact PI
HPV CAPSID ANTIBODIES$316,257
R37 · FY2008 · AI · contact PI
HPV: Biology, Clinical Significance and Epidemiology$1,958,158
P01 · FY2007 · CA · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$543,494
R01 · FY2007 · CA · contact PI
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS$378,962
P01 · FY2007 · CA · contact PI
HPV CAPSID ANTIBODIES$322,548
R37 · FY2007 · AI · contact PI
Role of RecQ Helicases to Prevent Senescence By c-Myc$309,930
R01 · FY2007 · AG · contact PI
MOLECULAR BIOLOGY$296,166
P01 · FY2007 · CA · contact PI
ADMINISTRATION$139,882
P01 · FY2007 · CA · contact PI
Interactions of HPV Oncogenes With the p53 Pathway$543,423
R01 · FY2006 · CA · contact PI
HPV CAPSID ANTIBODIES$332,347
R37 · FY2006 · AI · contact PI
Role of RecQ Helicases to Prevent Senescence By c-Myc$319,185
R01 · FY2006 · AG · contact PI
HPV: Biology, Clinical Significance and Epidemiology$1,865,736
P01 · FY2005 · CA
Interactions of HPV Oncogenes With the p53 Pathway$519,408
R01 · FY2005 · CA
HPV CAPSID ANTIBODIES$315,228
R37 · FY2005 · AI
HPV: Biology, Clinical Significance and Epidemiology$2,007,998
P01 · FY2004 · CA
INTERACITONS OF HPV ONCOGENES WITH THE P53 PATHWAY$494,537
R01 · FY2004 · CA
HPV CAPSID ANTIBODIES$271,534
R37 · FY2004 · AI
HPV: Biology, Clinical Significance and Epidemiology$1,955,462
P01 · FY2003 · CA
INTERACITONS OF HPV ONCOGENES WITH THE P53 PATHWAY$483,052
R01 · FY2003 · CA
HPV CAPSID ANTIBODIES$295,990
R37 · FY2003 · AI
INTERACITONS OF HPV ONCOGENES WITH THE P53 PATHWAY$471,896
R01 · FY2002 · CA
HPV CAPSID ANTIBODIES$294,802
R37 · FY2002 · AI
HUMAN PAPILLOMAVIRUS EXPRESSION AND ANTIGENICITY$280,718
P01 · FY2002 · CA
INTERACITONS OF HPV ONCOGENES WITH THE P53 PATHWAY$417,514
R01 · FY2001 · CA
HPV CAPSID ANTIBODIES$295,898
R37 · FY2001 · AI
HUMAN PAPILLOMAVIRUS EXPRESSION AND ANTIGENICITY$280,718
P01 · FY2001 · CA
INTERACITONS OF HPV ONCOGENES WITH THE P53 PATHWAY$353,950
R01 · FY2000 · CA
HUMAN PAPILLOMAVIRUS EXPRESSION AND ANTIGENICITY$280,718
P01 · FY2000 · CA
HPV CAPSID ANTIBODIES$255,209
R37 · FY2000 · AI
HPV CAPSID ANTIBODIES$26,492
R37 · FY2000 · AI